RBC Bioscience

RBC Bioscience EBIT per Share

The EBIT per Share of RBC Bioscience (6848.TWO) as of Sep 28, 2026 is 2.72 TWD. In the previous year, EBIT per Share was 1.37 TWD — a change of 97.97% (higher).

EBIT per Share

2.72TWD

YoY

97.97%

Last updated:

EBIT per Share of RBC Bioscience is 2026 2.72 TWD. EBIT per Share of RBC Bioscience was 2025 1.37 TWD. It decreases by 97.97% higher compared to the previous year.

The RBC Bioscience EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2018
0.99 TWD
Jan 1, 2019
2.37 TWD
Jan 1, 2020
15.67 TWD
Jan 1, 2021
3.95 TWD
Jan 1, 2022
0.60 TWD
Jan 1, 2023
1.37 TWD
Jan 1, 2024
2.72 TWD
The RBC Bioscience EBIT per Share history
YEAREBIT per ShareYoY
2.72TWD+97.97%
1.37TWD+129.94%
0.60TWD-84.89%
3.95TWD-74.77%
15.67TWD+560.85%
2.37TWD+139.83%
0.99TWD—
Access this data via the Eulerpool API
Get Free API Key

RBC Bioscience Stock analysis

What does RBC Bioscience do? RBC Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RBC Bioscience stock

EBIT per Share of RBC Bioscience is 2.72 TWD in 2026.

EBIT per Share of RBC Bioscience changed from 1.37 TWD to 2.72 TWD, representing a 97.97% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share RBC Bioscience since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — RBC Bioscience

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — RBC Bioscience